Meridian's E. Coli Toxin Test Granted New Claim
go back to news archives Meridian Bioscience have announced that it has been granted FDA clearance to market an additional claim related to its ImmunoCard STAT!(R) E. coli O157 Plus. This test identifies the most dangerous Shiga toxin-producing E. coli bacteria that can cause severe kidney damage or death, especially in infected children under 5 years of age. This new claim will enable the toxin- producing E. coli O157 antigens to be detected from the most commonly used collection and transport culture medium, thereby reducing time and labor for the testing laboratory.
The first recognized U.S. outbreak of E. coli O157 was reported in 1982 and was associated with eating hamburgers from a particular fast-food chain. Since 1982, E. coli O157 outbreaks have occurred more frequently with approximately 13% of these due to food sources other than beef products. It is now estimated that, among children under 5 years of age, the incidence of infection can be as high as 6 per 100,000.
Source : Meridian Bioscience, Inc. View Company Information
Posted on January 24, 2003
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
USP Chapter <86> and the Move to Recombinant Methods
29 Apr 2025 -
2025 Novogene Sequencing Symposium
8 May 2025 -
Explore the Future of Sterility Testing with Rapid Micro Biosystems®
14 May 2025 -
Understanding USP <73> to Accelerate Sterility Testing for Short-Life Products
14 May 2025 -
British Society For Microbial Technology 40th Anniversary Microbiology Conference
15 May 2025 -
How Is VIDAS® KUBE™ Transforming Food Pathogen Detection?
19 May 2025 -
Sampling and Microbial Testing of Water and Data Trending
20 May 2025 -
European Microbiology Conference and Workshop 2025
20 May 2025 -
Future Labs Live 2025
27 May 2025 -
2025 Endotoxin Testing Summit
10 Jun 2025